Jasper Therapeutics Cash from Financing (TTM) Trends

Jasper Therapeutics Inc (JSPR)

24.08 +0.09 (+0.38%) USD | NASDAQ | May 02, 16:00

23.10 -0.98 (-4.07%) Pre-Market: 08:24

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2021. Upgrade now.

Date	Value
December 31, 2023	100.97M
September 30, 2023	101.27M
June 30, 2023	101.24M
March 31, 2023	101.55M
December 31, 2022	0.055M

Date	Value
September 30, 2022	-0.882M
June 30, 2022	90.84M
March 31, 2022	90.23M
December 31, 2021	100.97M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.882M

Minimum

Sep 2022

101.55M

Maximum

Mar 2023

76.25M

Average

100.97M

Median

Dec 2021

Cash from Financing (TTM) Benchmarks